CIPO Patents = 3

EPO Patents = 1

Forward Citations = 1

Loading Chart...

6 inventors (with patents filed for the assignee):

Richard Llewellyn Sydney Forster (5 out of 17 patents)

James Douglas Watson (5 out of 21 patents)

Damian Jay White (4 out of 4 patents)

4. Clare Elton (3 patents)

5. David Rex Musgrave (0 patent)

6. David Rex Musgrave (0 patent)

5 patents: Sort by Forward Citations

1. 8784795 - Methods for determining personalized treatment compositions for prostate cancer and breast cancer (2014-07-22),

2. 8703127 - Methods and materials for the diagnosis of prostate cancers (2014-04-22),

3. 8658166 - Methods and materials for the diagnosis of prostate cancers (2014-02-25),

4. 8658164 - Methods and materials for the diagnosis of prostate cancers (2014-02-25),

5. 8632971 - Methods and materials for determining the efficacy of prostate cancer therapies (2014-01-21),

Caldera Health Limited is a biotechnology company focused on developing innovative diagnostic tests for detecting prostate cancer at an early stage. Their groundbreaking technology aims to improve patient outcomes and reduce healthcare costs by providing accurate and timely diagnosis. Caldera Health is committed to advancing precision medicine in the field of oncology through cutting-edge research and collaboration with leading experts in the industry.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

5 Patents

#60 in Auckland

#152 in New Zealand

Auckland, New Zealand

Caldera Health Limited

Forward Citations = 1

6 inventors:

Richard Llewellyn Sydney Forster (5 out of 17 patents)

James Douglas Watson (5 out of 21 patents)

Damian Jay White (4 out of 4 patents)

4. Clare Elton (3 patents)

5. David Rex Musgrave (0 patent)

Please report any incorrect information to support@idiyas.com

3 patents (CIPO):

Please report any incorrect information to support@idiyas.com

1 patent (EPO):

Please report any incorrect information to support@idiyas.com